Gregory Adey, MD
Urology · Portland, MENPI 1578506143
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,112 of the $1,502 with a category attached, or 74.1%. 16 manufacturers reported payments, led by Procept Biorobotics Corporation at 39.9% of the total. Reporting peaked in 2024 at $549 and has fallen 78.8% since, to $116 in 2025.
Across 36 payments — averaging $41.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$599
- Boston Scientific$162
- Coloplast$157
- AbbVie$85
- Axonics, Inc.$83
- Johnson & Johnson$78
- plus $338 from 10 others
What the payments were for
- Travel & lodging$33022%
- Food & beverage$1,11274%
- Education$604%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 6 | $599 |
| Boston Scientific | 6 | $162 |
| Coloplast | 3 | $157 |
| AbbVie | 4 | $85 |
| Axonics, Inc. | 1 | $83 |
| Johnson & Johnson | 3 | $78 |
| Pfizer | 3 | $63 |
| Convatec Inc. | 1 | $47 |
| Urogen Pharma, Inc. | 1 | $41 |
| Dentsply IH Inc. | 2 | $29 |
| 180 Medical, Inc. | 1 | $28 |
| Tolmar, Inc. | 1 | $27 |
| Photocure Inc | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Neotract Inc. | 1 | $26 |
| Myovant Sciences Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,502 in reported general payments places this provider in the 60th percentile of 59 urology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 35 | $94,751 |
| Tamsulosin Hcl | 404 | $5,819 |
| Finasteride | 369 | $3,677 |
| Potassium Citrate ErPotassium Citrate | 23 | $3,032 |
| Oxybutynin Chloride ErOxybutynin Chloride | 80 | $2,191 |
| Testosterone | 31 | $1,701 |
| Desmopressin Acetate | 21 | $1,529 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 35 | $1,083 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $685 |
| Doxazosin Mesylate | 49 | $654 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 65 | $377 |
| Dutasteride | 12 | $350 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 20 | $349 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $267 |
| Terazosin Hcl | 19 | $262 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Orgovyx | $26 | $94,75135 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 59 urology providers in Maine.
Other urology in Portland
- David SobelPortland$58K
- Marc HodroffPortland$17K
- Gabriel BelangerPortland$2K
- Benjamin ScollPortland$784
- Griffith BatstoneFarmington$123K
- Evan DunnLewiston$9K
- Robert FisherRockport$9K
- Christopher HenryLewiston$6K
- Jesse SammonSouth Portland$6K
- Sanchita BoseSouth Portland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.